{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:45:19Z","timestamp":1794545119502,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant nephrosclerosis is a thrombotic microangiopathy associated with abnormal local activation of the complement alternative pathway (AP). However, the mechanism underlying local AP activation is not fully understood. We hypothesized that complement factor D (CFD) secreted by endothelial cells triggers vascular dysfunction in malignant nephrosclerosis via local complement activation. We investigated the deposition of CFD in human kidney biopsy tissues and the function of endothelial-derived CFD in endothelial cell cultures. Immunofluorescence microscopy and laser microdissection-targeted mass spectrometry revealed significant deposition of CFD in the kidneys of patients with malignant nephrosclerosis. Conditionally immortalized human glomerular endothelial cells (CiGEnCs) continuously expressed and secreted CFD in vitro. CFD knockdown in CiGEnCs by small interfering RNA reduced local complement activation and attenuated the upregulation of intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), von Willebrand factor (VWF), and endothelin-1 (ET-1) induced by Ang II. The expression of CFD in CiGEnCs was significantly higher than that in other types of microvascular endothelial cells. Our findings suggest that (i) glomerular endothelial cells are an important source of local renal CFD, (ii) endothelial-derived CFD can activate the local complement system, and (iii) endothelial-derived CFD mediates endothelial dysfunction, which may play a role in the pathogenesis of malignant nephrosclerosis.<\/jats:p>","DOI":"10.1038\/s41440-023-01300-3","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:14:57Z","timestamp":1684152897000},"page":"1759-1770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation"],"prefix":"10.1038","volume":"46","author":[{"given":"Zheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"1300_CR1","doi-asserted-by":"publisher","unstructured":"Zhang Y, Yang C, Zhou X, Hu R, Quan S, Zhou Y, et al. Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis. Nephrol Dial Transpl. 2020 (e-pub ahead of print 20201226; https:\/\/doi.org\/10.1093\/ndt\/gfaa280.","DOI":"10.1093\/ndt\/gfaa280"},{"key":"1300_CR2","doi-asserted-by":"publisher","first-page":"H349","DOI":"10.1152\/ajpheart.00759.2016","volume":"312","author":"UO Wenzel","year":"2017","unstructured":"Wenzel UO, Bode M, K\u00f6hl J, Ehmke H. A pathogenic role of complement in arterial hypertension and hypertensive end organ damage. Am J Physiol Heart Circ Physiol. 2017;312:H349\u2013h354.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1300_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ajh\/hpx008","volume":"30","author":"A Shantsila","year":"2017","unstructured":"Shantsila A, Lip GYH. Malignant hypertension revisited-does this still exist? Am J Hypertens. 2017;30:543\u20139.","journal-title":"Am J Hypertens"},{"key":"1300_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"1300_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part i - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262.","journal-title":"Front Immunol"},{"key":"1300_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement system part II: role in immunity. Front Immunol. 2015;6:257.","journal-title":"Front Immunol"},{"key":"1300_CR7","doi-asserted-by":"publisher","first-page":"20160221","DOI":"10.1098\/rstb.2016.0221","volume":"372","author":"C Bayly-Jones","year":"2017","unstructured":"Bayly-Jones C, Bubeck D, Dunstone MA. The mystery behind membrane insertion: a review of the complement membrane attack complex. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160221.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1300_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nri3761","volume":"14","author":"M Kolev","year":"2014","unstructured":"Kolev M, Le Friec G, Kemper C. Complement-tapping into new sites and effector systems. Nat Rev Immunol. 2014;14:811\u201320.","journal-title":"Nat Rev Immunol"},{"key":"1300_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/ki.1997.487","volume":"52","author":"M Nangaku","year":"1997","unstructured":"Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, et al. Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int. 1997;52:1570\u20138.","journal-title":"Kidney Int"},{"key":"1300_CR10","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1681\/ASN.2018020184","volume":"29","author":"S Timmermans","year":"2018","unstructured":"Timmermans S, Abdul-Hamid MA, Potjewijd J, Theunissen R, Damoiseaux J, Reutelingsperger CP, et al. C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension. J Am Soc Nephrol. 2018;29:2234\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"1300_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/modpathol.2017.154","volume":"31","author":"CP Larsen","year":"2018","unstructured":"Larsen CP, Wilson JD, Best-Rocha A, Beggs ML, Hennigar RA. Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy. Mod Pathol. 2018;31:488\u201394.","journal-title":"Mod Pathol"},{"key":"1300_CR12","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","volume":"91","author":"S Timmermans","year":"2017","unstructured":"Timmermans S, Abdul-Hamid MA, Vanderlocht J, Damoiseaux J, Reutelingsperger CP, van Paassen P. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities. Kidney Int. 2017;91:1420\u20135.","journal-title":"Kidney Int"},{"key":"1300_CR13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00109-021-02133-8","volume":"99","author":"C Menendez-Castro","year":"2021","unstructured":"Menendez-Castro C, Cordasic N, Fahlbusch FB, Ekici AB, Kirchner P, Daniel C, et al. RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertension. J Mol Med. 2021;99:1727\u201340.","journal-title":"J Mol Med"},{"key":"1300_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jash.2015.12.007","volume":"10","author":"RO Mathew","year":"2016","unstructured":"Mathew RO, Nayer A, Asif A. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. J Am Soc Hypertens. 2016;10:352\u20139.","journal-title":"J Am Soc Hypertens"},{"key":"1300_CR15","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:1676\u201387.","journal-title":"N Engl J Med"},{"key":"1300_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1681\/ASN.2015050502","volume":"27","author":"RJ Johnson","year":"2016","unstructured":"Johnson RJ, Nangaku M. Endothelial dysfunction: the secret agent driving kidney disease. J Am Soc Nephrol. 2016;27:3\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"1300_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","volume":"188","author":"R Lubbers","year":"2017","unstructured":"Lubbers R, van Essen MF, van Kooten C, Trouw LA. Production of complement components by cells of the immune system. Clin Exp Immunol. 2017;188:183\u201394.","journal-title":"Clin Exp Immunol"},{"key":"1300_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","volume":"39","author":"MK Liszewski","year":"2013","unstructured":"Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity. 2013;39:1143\u201357.","journal-title":"Immunity."},{"key":"1300_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2021.05.033","volume":"100","author":"S Mahajan","year":"2021","unstructured":"Mahajan S, Jacob A, Kelkar A, Chang A, McSkimming D, Neelamegham S, et al. Local complement factor H protects kidney endothelial cell structure and function. Kidney Int. 2021;100:824\u201336.","journal-title":"Kidney Int"},{"key":"1300_CR20","doi-asserted-by":"publisher","first-page":"e007818","DOI":"10.1161\/JAHA.117.007818","volume":"7","author":"D Jalal","year":"2018","unstructured":"Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, et al. Endothelial microparticles and systemic complement activation in patients with chronic kidney disease. J Am Heart Assoc. 2018;7:e007818.","journal-title":"J Am Heart Assoc"},{"key":"1300_CR21","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1167\/iovs.11-7933","volume":"52","author":"CM Stanton","year":"2011","unstructured":"Stanton CM, Yates JR, den Hollander AI, Seddon JM, Swaroop A, Stambolian D, et al. Complement factor D in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:8828\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1300_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/pro.5560050401","volume":"5","author":"JE Volanakis","year":"1996","unstructured":"Volanakis JE, Narayana SV. Complement factor D, a novel serine protease. Protein Sci. 1996;5:553\u201364.","journal-title":"Protein Sci"},{"key":"1300_CR23","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/rheumatology\/kez517","volume":"59","author":"T Miyagawa","year":"2020","unstructured":"Miyagawa T, Taniguchi T, Saigusa R, Fukayama M, Takahashi T, Yamashita T, et al. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis. Rheumatol (Oxf). 2020;59:2005\u201315.","journal-title":"Rheumatol (Oxf)"},{"key":"1300_CR24","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1182\/blood.2020008248","volume":"136","author":"J Yu","year":"2020","unstructured":"Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020;136:2080\u20139.","journal-title":"Blood."},{"key":"1300_CR25","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.ki.5000277","volume":"69","author":"SC Satchell","year":"2006","unstructured":"Satchell SC, Tasman CH, Singh A, Ni L, Geelen J, von Ruhland CJ, et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 2006;69:1633\u201340.","journal-title":"Kidney Int"},{"key":"1300_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/030098589703400113","volume":"34","author":"CS Elangbam","year":"1997","unstructured":"Elangbam CS, Qualls CW Jr, Dahlgren RR. Cell adhesion molecules-update. Vet Pathol. 1997;34:61\u201373.","journal-title":"Vet Pathol"},{"key":"1300_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00438146","volume":"12","author":"O Chappey","year":"1996","unstructured":"Chappey O, Wautier MP, Boval B, Wautier JL. Endothelial cells in culture: an experimental model for the study of vascular dysfunctions. Cell Biol Toxicol. 1996;12:199\u2013205.","journal-title":"Cell Biol Toxicol"},{"key":"1300_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1734-1140(09)70004-0","volume":"61","author":"C Lawson","year":"2009","unstructured":"Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharm Rep. 2009;61:22\u201332.","journal-title":"Pharm Rep."},{"key":"1300_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0008-6363(97)00039-4","volume":"34","author":"GY Lip","year":"1997","unstructured":"Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255\u201365.","journal-title":"Cardiovasc Res"},{"key":"1300_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1538-7836.2006.01949.x","volume":"4","author":"UM Vischer","year":"2006","unstructured":"Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4:1186\u201393.","journal-title":"J Thromb Haemost"},{"key":"1300_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.phrs.2011.01.012","volume":"63","author":"A Ergul","year":"2011","unstructured":"Ergul A. Endothelin-1 and diabetic complications: focus on the vasculature. Pharm Res. 2011;63:477\u201382.","journal-title":"Pharm Res"},{"key":"1300_CR32","doi-asserted-by":"publisher","first-page":"v23","DOI":"10.1093\/rheumatology\/ken282","volume":"47","author":"D Abraham","year":"2008","unstructured":"Abraham D, Dashwood M. Endothelin-role in vascular disease. Rheumatol (Oxf). 2008;47:v23\u201324.","journal-title":"Rheumatol (Oxf)"},{"key":"1300_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","volume":"8","author":"JR Pratt","year":"2002","unstructured":"Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med. 2002;8:582\u20137.","journal-title":"Nat Med"},{"key":"1300_CR34","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/0140-6736(93)92362-W","volume":"342","author":"SH Sacks","year":"1993","unstructured":"Sacks SH, Zhou W, Andrews PA, Hartley B. Endogenous complement C3 synthesis in immune complex nephritis. Lancet 1993;342:1273\u20134.","journal-title":"Lancet"},{"key":"1300_CR35","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1681\/ASN.V7112428","volume":"7","author":"M Miyazaki","year":"1996","unstructured":"Miyazaki M, Abe K, Koji T, Furusu A, Ozono Y, Harada T, et al. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J Am Soc Nephrol. 1996;7:2428\u201333.","journal-title":"J Am Soc Nephrol"},{"key":"1300_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1096\/fj.05-4747com","volume":"20","author":"CA Farrar","year":"2006","unstructured":"Farrar CA, Zhou W, Lin T, Sacks SH. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J. 2006;20:217\u201326.","journal-title":"FASEB J"},{"key":"1300_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","volume":"28","author":"MG Strainic","year":"2008","unstructured":"Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity. 2008;28:425\u201335.","journal-title":"Immunity."},{"key":"1300_CR38","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","volume":"112","author":"PN Lalli","year":"2008","unstructured":"Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood. 2008;112:1759\u201366.","journal-title":"Blood."},{"key":"1300_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0022-1759(84)90470-8","volume":"67","author":"SR Barnum","year":"1984","unstructured":"Barnum SR, Niemann MA, Kearney JF, Volanakis JE. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. J Immunol Methods. 1984;67:303\u20139.","journal-title":"J Immunol Methods"},{"key":"1300_CR40","doi-asserted-by":"publisher","first-page":"607211","DOI":"10.3389\/fimmu.2020.607211","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ghiringhelli Borsa N, Shao D, Dopler A, Jones MB, Meyer NC, et al. Factor H autoantibodies and complement-mediated diseases. Front Immunol. 2020;11:607211.","journal-title":"Front Immunol"},{"key":"1300_CR41","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1084\/jem.148.6.1722","volume":"148","author":"RD Schreiber","year":"1978","unstructured":"Schreiber RD, M\u00fcller-Eberhard HJ. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins. J Exp Med. 1978;148:1722\u20137.","journal-title":"J Exp Med"},{"key":"1300_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semnephrol.2015.01.010","volume":"35","author":"SK Verma","year":"2015","unstructured":"Verma SK, Molitoris BA. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin Nephrol. 2015;35:96\u2013107.","journal-title":"Semin Nephrol"},{"key":"1300_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","volume":"15","author":"N Jourde-Chiche","year":"2019","unstructured":"Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, et al. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15:87\u2013108.","journal-title":"Nat Rev Nephrol"},{"key":"1300_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000168646","volume":"13","author":"BS Daniels","year":"1993","unstructured":"Daniels BS. The role of the glomerular epithelial cell in the maintenance of the glomerular filtration barrier. Am J Nephrol. 1993;13:318\u201323.","journal-title":"Am J Nephrol"},{"key":"1300_CR45","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1242\/jcs.108.6.2369","volume":"108","author":"WG Roberts","year":"1995","unstructured":"Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108:2369\u201379.","journal-title":"J Cell Sci"},{"key":"1300_CR46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2215\/CJN.09400913","volume":"9","author":"MR Pollak","year":"2014","unstructured":"Pollak MR, Quaggin SE, Hoenig MP, Dworkin LD. The glomerulus: the sphere of influence. Clin J Am Soc Nephrol. 2014;9:1461\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1300_CR47","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1248\/bpb.b19-00531","volume":"42","author":"T Minami","year":"2019","unstructured":"Minami T, Muramatsu M, Kume T. Organ\/tissue-specific vascular endothelial cell heterogeneity in health and disease. Biol Pharm Bull. 2019;42:1609\u201319.","journal-title":"Biol Pharm Bull"},{"key":"1300_CR48","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.4049\/jimmunol.156.8.3051","volume":"156","author":"MA Naughton","year":"1996","unstructured":"Naughton MA, Botto M, Carter MJ, Alexander GJ, Goldman JM, Walport MJ. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol. 1996;156:3051\u20136.","journal-title":"J Immunol"},{"key":"1300_CR49","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1074\/jbc.RA118.002639","volume":"293","author":"SE Sartain","year":"2018","unstructured":"Sartain SE, Turner NA, Moake JL. Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells. J Biol Chem. 2018;293:7195\u2013208.","journal-title":"J Biol Chem"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01300-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T23:06:15Z","timestamp":1688511975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01300-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01300-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"11 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}